We are a dermatological pharmaceuticals house engineering foams, gels, sprays, creams and film-forming systems for the diseases people carry every day — androgenetic alopecia, melasma, tinea, acne, scars, and the vascular fragilities of ageing skin.
Most therapeutic actives already exist. What has held medicine back is the vehicle — the foam, the gel, the film — that carries a molecule across the stratum corneum without irritating what it touches. Xhealth is built around that single problem, worked from three angles.
We partner with pharmaceutical manufacturers on four continents to bring long-proven actives to the markets that need them most — with the paperwork, stability data and pharmacovigilance to match.
Our in-house formulation team specialises in complex topical vehicles: polysaccharide gels, permeation-enhanced foams, film-forming lacquers, eutectic sprays and long-residence creams tuned for scalp, nail, mucosa and inflamed skin.
We supply our own products through a specialty channel of dermatology clinics, hospital pharmacies and specialist retailers — and, in the same markets, import premium dermatology brands from trusted partners, with medical education and pharmacovigilance built in.
A quick-drying, non-greasy foam vehicle — no propylene glycol — engineered to deliver minoxidil to the follicle and stay there.
A single-application film that releases terbinafine over a full course. One tube, one treatment, one week of shoes back on.
Depigmenting cream for melasma, chloasma, freckles, age spots and post-inflammatory hyperpigmentation.
Clinically tested home cryotherapy that freezes warts and verrucas to the core. Pain-free, results in 10–14 days after one application.
Mucopolysaccharide heparinoid cream/gel for bruises, superficial thrombophlebitis and dry, ageing skin.
Mucopolysaccharide polysulfate (MPS) is a semi-synthetic glycosaminoglycan — a long, sulphated chondroitin backbone with dense hydrogen-bonding surfaces. Applied topically, it pulls water into the outermost dermis and stimulates endogenous hyaluronate synthesis, restoring viscoelasticity to skin that has lost it.
Over five decades of clinical use, MPS creams have been documented for hydration, anti-inflammation, microcirculation and superficial thrombolysis — the pharmacological backbone of Hirudiox®.
We ship pharmaceutical products. That means we own every step — the actives we choose, the vehicles we build them into, the paperwork behind them, and the patients who eventually rub them into skin.VALERIE TONG CMO, APPOLO TRADING CO., LTD
A read-through of the 2025 Nature Reviews Disease Primers update on AGA — genetics, DHT signalling, PRP, dutasteride, and where topicals now sit.
Why fast-breaking foams outperform creams for scalp penetration — surface tension, evaporation kinetics and the humble Xcare 5% cassette.
A 2025 JAAD consensus reframes melasma as a chronic dermatosis. What that means for hydroquinone, triple-combination therapy and long-term maintenance.
Whether you're a specialist clinic building a dispensary, a pharmacy chain expanding dermatology, or a distributor looking for evidence-based topical brands — we have a partnership model that fits.